Co-Diagnostics Completes Validation for FDA 510(k) Submission
SALT LAKE CITY, Utah, July 1, 2026 Co-Diagnostics, Inc. has reached a significant regulatory milestone by completing the clinical...
RSV
Advertisement
Merck ENFLONSIA Approved in EU for Infant RSV Protection
RAHWAY, N.J., April 17, 2026 Merck & Co., Inc. announced that the European Commission (EC) has approved ENFLONSIA™ (clesrovimab),...
Gilead Showcases New Virology Data Spanning HIV, Hepatitis, and respiratory diseases
Foster City, California – October 20, 2025 — Gilead Sciences, Inc. (Nasdaq: GILD) announced that it will present new...
Sanofi Strengthens Vaccine Pipeline with Acquisition of Vicebio
Paris, France — August 21, 2025 – Sanofi has announced the acquisition of Vicebio, a biotechnology company specializing in...
Advertisement
